The Masterclass has been approved by the RACGP for 40 Category 1 CPD points. RACGP members are invited to complete the pre-Masterclass activity which is compulsory if you want to apply for Category 1 CPD points. Completion of the post-course activity is also compulsory if you want to receive Category 1 CPD points also.


The following Pre-Masterclass activity applies to RACGP members who wish to apply for Category 1 CPD points (note: confirmation of RACGP approval for this Masterclass will be confirmed at least 2 weeks prior to the event):

Read the following papers and complete the written reflection below:

·        Tambaro S, Bortolato M. Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. Recent Pat CNS Drug Discovery 2012; 7(1): 25-40. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691841/

  • Feingold D, Brill S, Goor-Aryeh I et al. Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. J Affective Disorders 2017; 218: 1–7 Click here for link to PDF of paper

Written Reflection (1200 words maximum)

Reflect on whether the various forms of evidence support presented in these papers do or don’t support a role for medicinal cannabis in the treatment of anxiety and depression, and what gaps in knowledge might be present? As a clinician, what would you want in terms of evidence (or further evidence) in order to feel confident prescribing medicinal cannabis for these conditions? 1200 words maximum.

Submit your written discussion to: kylie.obrien@ghi.life by 13 July 2019 if you intend to claim Category 1 RACGP CPD points.


Design a FAQ (Frequently Asked Questions) sheet suitable for your clinic focused on medicinal cannabis treatment of anxiety.

Submit your post-Masterclass activity tokylie.obrien@ghi.life by 15 August 2019 if you intend to claim Category 1 RACGP CPD points. Submissions after this date will not be accepted.